Sign In
Buy CIK
$2.53
-0.0100 (-0.394%)
At Close: Jun 02, 2026
Exclusive: European banks face indigenous calls to end Amazon oil trade
03:12am, Wednesday, 12'th Aug 2020
European banks committed to backing action on climate change face allegations of double standards from indigenous groups in Ecuador after a report named them as major players in the trade in oil from
Upland Software Announces Pricing of Public Offering of its Common Stock
12:00am, Wednesday, 12'th Aug 2020
Upland Software, Inc. (Nasdaq: UPLD), a leader in cloud-based tools for digital transformation, today announced the pricing of an underwritten public
Inflation May Be Coming Soon
07:34pm, Tuesday, 11'th Aug 2020
Many investors and analysts are expecting that inflation will be accelerating soon because of all the liquidity that the Federal Reserve has inserted into the system.
XPeng Seeks U.S. IPO Capital (Pending:XPEV)
07:09pm, Tuesday, 11'th Aug 2020
XPeng has filed to raise capital from a U.S. IPO.
NIO Limited (NIO) CEO William Li on Q2 2020 Results - Earnings Call Transcript
07:07pm, Tuesday, 11'th Aug 2020
NIO Limited (NYSE:NIO) Q2 2020 Results Earnings Conference Call August 11, 2020 08:00 AM ET Company Participants Rui Chen - Director, Investor Relations William Li - Founder, Chairman and Chief Execut
UNICREDIT SPA : UBS maintient sa recommandation neutre | Zone bourse
11:21am, Tuesday, 11'th Aug 2020U.S. insurers' coronavirus costs are less than feared so far
12:00am, Tuesday, 11'th Aug 2020
U.S. insurers' coronavirus costs are less than feared so far
IPO Update: CureVac Readies Plans For U.S. IPO (Pending:CVAC)
04:44pm, Monday, 10'th Aug 2020
CureVac has filed to raise $200 million in a U.S. IPO and another $118 million in a concurrent private placement.
UNICREDIT SPA : Credit Suisse optimiste sur le dossier | Zone bourse
02:01pm, Monday, 10'th Aug 2020UNICREDIT SPA : Opinion positive de Morgan Stanley | Zone bourse
01:46pm, Monday, 10'th Aug 2020CureVac aims to raise up to $245 million in U.S. IPO
01:40pm, Monday, 10'th Aug 2020
CureVac, one of Germany's leading contenders to develop a COVID-19 vaccine, said it aims to raise up to $245 million in an initial public stock offering (IPO) on the U.S. Nasdaq.
